-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA: APPROVES GAZYVA (OBINUTUZUMAB) INJECTION TO TREAT PRIMARY MEMBRANOUS NEPHROPATHY IN ADULTS - WEBSITE

Reuters·11/13/2026 23:09:13

Please log in to view news